168澳洲幸运10开奖官网网站: Product Recalls 开奖官网 开奖官网直播视频 开奖官网开奖计划 官网网页推荐 开奖官网网站苹果

Champix 0,5 mg and 1,0 mg (varenicline) film coated Tablets – combo

Following 开奖结果查询官网直播 正规官网开奖记录 开奖官网直播2024 开奖官方2024结果 results that indicated levels of increased N-nitroso-varenicline that exceed the Acceptable Daily Intake (ADI) threshold of 733 ng/day calculated by Pfizer, based on ICH M7 guidance, Pfizer Laboratories (Pty) Ltd in South Africa took the decision to initiate a voluntary recall on Champix, batch 18069 and notified SAHPRA Regulatory Compliance Units. Recall process: Recall letter distributed to all healthcare professionals via medpages.

ZAARIO 50 and ZAARIO 100 film coated Tablets (lorsatan potassium)

The products are being recalled due to quality defect: the presence of a mutagenic impurity above the threshold limit observed during analysis, as requested by the European Directorate for the Quality of Medicines and Healthcare (EDQM) on new Azido impurities [the presence of Azido (5-AMBBT) mutagesic impurity beyond total threshold limit was observed during analysis].

Clonam 0.5 mg and Clonam 2 mg film coated Tablets (clonazepam)`

The products are being recalled due to quality defect: the tablet description should be cross-scored, but instead the tablet has only a single score.